10 results
Reduced DOAC Dosing for Atrial Fibrillation 

#DOAC #Reduced #Dosing #Reduction #Dose #Anticoagulation #Pharmacology #AFib #Renal #CKD
Reduced DOAC Dosing ... DOAC #Reduced #Dosing ... Anticoagulation #Pharmacology ... #AFib #Renal #CKD
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... hypoglycaemic agents ... #Medications #Pharmacology ... #Dosing #Dosing ... Renal #Impairment #CKD
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... adults, <3g in CKD ... avoid NSAIDs if CKD ... • Neuropathic agents ... #agents #internship
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Equianalgesic Chart - Agents ... and Dosing #Management ... #Pain #Pharmacology ... Equianalgesics #Conversion ... #Doses #Dosing
Algorithm for Metformin Prescribing and Dosing in CKD
Dose Initiation - Immediate release:
 • Initial 500 mg
Algorithm for Metformin ... Prescribing and Dosing ... in CKD Dose Initiation ... #CKD #pharmacology ... #algorithm #diabetes
DOAC: Cheat Sheet - Atrial Fibrillation, VTE Prophylaxis, VTE and Renal Dosing

Renal Dosing:
Apixaban (25% renal clearance):
VTE and Renal Dosing ... Renal Dosing ... recommend alternative agent ... AFib: CrCl 15-50 ... Anticoagulation #Hematology #Pharmacology
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
patients with CKD ... phosphate binding agents ... Purposes Only* #CKD ... Hyperphosphatemia #Dose #Dosing ... #Pharmacology #
Acute Atrial Fibrillation - Initial Options for Rate Control
Diltiazem IV
 •  Rapid onset and rapidly
ADHF • Risks conversion ... • 3rd line agent ... Rate #Control #pharmacology ... management #cardiology #AFib
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... Switching between oral agents ... Switching between oral agents ... Inhibitor #switching #conversion ... ticagrelor #prasugrel #pharmacology
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
ANTAGONIST (ARB) DOSING ... SWITCHING BETWEEN AGENTS ... an alternative agent ... ReceptorBlocker #Pharmacology ... #Conversion #Switching